Blog - Page 3911 of 5774

MondayMay 24, 2010 9:33 am

Shrink Nanotechnologies, Inc. (INKN.OB) Files Major Patent on Rapid Prototyping System

One company that is starting to capture the imagination of investors is Shrink Nanotechnologies, Inc. Located in Carlsbad, California, Shrink is a one-of-a-kind FIGA organization which focuses on leveraging contributions from experts in the fields of Finance, Industry, Government and Academia (FIGA). Today, Shrink took a major step towards enhancing its future with the announcement that their Biotech R & D Group has filed a patent on a rapid prototyping system for the manufacture of microfluidic chips, or Lab-on-a-Chip (LOC) devices. The patent will allow Shrink to make its presence felt in the biochip market which has evolved into a…

MondayMay 24, 2010 8:38 am

China Crescent Enterprises, Inc. (CCTR.OB) Video Chart for Monday, May 24, 2010

CCTR failed to make a big move a few weeks ago. It is now back down on a support level and we are looking for it to once again hold support and attempt a larger move. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=403 Let us hear your thoughts below:

MondayMay 24, 2010 7:48 am

Newport Digital Technologies, Inc. (NPDT.OB) Announces a Co-Marketing Campaign with Ingram Micro (NYSE: IM)

Newport Digital Technologies, Inc. announced this morning that it has developed a co-marketing campaign with the Ingram Micro Data Capture/POS Division to introduce the N37B ruggedized mobile computing device solution to the distributor’s U.S. value added reseller (VAR) channel. NPDT has begun a campaign that incorporates both internal sales and VAR reseller engagement activities, including attendance at the Ingram Micro Data Capture/POS Partner Invitational, GovEd Alliance events, and an upcoming WebEx scheduled to take place June 17, 2010. NPDT’s N37B ruggedized mobile computer is a full featured device, certified by AT&T, for industrial applications such as inventory management, asset tracking,…

MondayMay 24, 2010 6:56 am

Ecochild Inc. (ECOH.OB) Subsidiary Retains CCG Investor Relations for Campaign

Today, Ecochild Inc.’s wholly owned subsidiary, AIVtech Holding Limited, announced that it has contracted CCG Investor Relations for the design and execution of its investor relations campaign. The company utilizes its subsidiaries to manufacture and market its electronic furniture, digital/multimedia speakers, and LCD/LED televisions. Considered a fast-growing manufacturer of multimedia electronics, AIVtech’s 2009 revenues stem solely from the sales of electronic furniture and digital/multimedia speakers; the company reported revenues of $38.5 million, with a full-year 2009 net income of $7.5 million, an increase of 91.9% over 2008. JinLin Guo, AIVtech Chairman and CEO, commented, "We look forward to working with…

MondayMay 24, 2010 6:53 am

Divine Skin Inc. (DSKX.OB) Opens its First Day of Trading Up

Divine Skin Inc. announced on Friday, May 21, 2010, that they opened their first day of trading up at $0.30. The newly public company evolved out of their flagship brand, DS Laboratories. Growing quickly without investment capital until 2009, DS Laboratories then conducted a private placement. Founder and Chief Executive Officer, Mr. Daniel Khesin, said the Company's rapid expansion came through "exhaustive research, out-of-the-box thinking, and entrepreneurial drive." Divine Skin Inc. develops and markets cosmeceuticals under a few brands. DS Laboratories (DS) specializes in restoring growth and radiance to hair; suppressing dandruff and unwanted hair; balancing natural flora to enhance…

MondayMay 24, 2010 6:49 am

Cord Blood America, Inc. (CBAI.OB) Releases Update on First Quarter 2010 Achievements

Cord Blood America, Inc., the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and families nationwide and internationally, recently released an update to investors on the company’s achievements during the first quarter of 2010. Cord Blood America’s co-founder and chief executive officer, Matthew Schissler, reviewed first quarter results and progress in an interview with analyst Francis Gaskins. The entire interview is available at: www.gaskinsco.com/cbai-5-20-10.mp3. Mr. Schissler noted in the interview that the company is on-track with its partnership with AXM Pharma to open the world’s largest stem cell storage and processing facility in…

MondayMay 24, 2010 6:46 am

Manas Petroleum Corp. (MNAP.OB) Posts Q1 Results

Manas Petroleum Corp. recently filed and posted its first-quarter results for the three months ended March 31, 2010. The company reported net income of $83.0 million as compared to a net loss of $2.20 million for the first quarter of 2009. Manas Petroleum attributes the increase mainly to the $57.8 million gain from the sale of Manas Adriatic GmbH and a change in fair value of investment in associate of $28.8 million. Manas' operating expenses for the first quarter increased to $3.2 million as compared to $2.5 million for the same period in 2009. The company attributes the 29 percent…

MondayMay 24, 2010 6:44 am

Sorrento Therapeutics, Inc. (SRNE.OB) Receives Grant to Support Development of Staph Fighting Therapeutics

Sorrento Therapeutics Inc. Friday announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases to assist Sorrento in its programs to generate and develop novel antibody therapeutics and vaccines to against Staphylococcus aureus (staph) infections. Phase I of the grant is for $300,000 annually for two years, with the possibility of phase II funding of $1 million per year for up to three years thereafter. According to the Centers for Disease Control and Prevention, in 2005 about 94,000 serious staph infections occurred in the U.S., resulting…

FridayMay 21, 2010 3:47 pm

Keyuan Petrochemicals, Inc. (SVPE) Reports Large Jump in Net Income and Revenue

Keyuan Petrochemicals, Inc. reported net income of $6.7 million in the first quarter of 2010, compared to a net loss of $8.8 million in the last quarter of 2009. Keyuan Petrochemicals, Inc. reported revenue of $117.4 million in the first quarter of 2010. The company had no revenue in the first quarter of 2009 as it began operations in October 2009. Revenues in the final quarter of 2009 came in at $68.7 million. Keyuan Petrochemicals, Inc. sold 144,746 metric tons of different petrochemical products in the first quarter of 2010. This represented a large sequential increase from the 96,690 metric…

FridayMay 21, 2010 3:45 pm

Spherix Inc. (SPEX) Reports Progress On Phase 3 Trial for Diabetes Drug

Spherix Inc. reported progress on a Phase 3 clinical trial for its new drug to treat Type 2 diabetes and expects results in the third quarter of 2010. Spherix is developing D-tagatose, which is used to reduce blood sugar levels in patients suffering from Type 2 diabetes. D-tagatose works by decreasing glycogen utilization in the body, which leads to better control of blood sugar. Spherix has two clinical trials underway for D-tagatose with the Food and Drug Administration (FDA) under the Investigational New Drug Application (NDA) format with the agency. The company has a Phase 2 trial to evaluate D-tagatose…

Site Search

Company Search